Happiness Development Group Limited (HAPP) Research

Operating both domestically in the People's Republic of China and across international markets, Happiness Development Group Limited (formerly Happiness Biotech Group Limited until October 2022) specializes in the research, creation, and sale of nutraceuticals and dietary supplements. Their extensive product catalog includes traditional Chinese medicinal extracts like lucidum spore powders, cordyceps mycelia, Ejiao, and American ginseng, alongside a variety of other herbal and animal extracts, vitamins, minerals, and amino acids. Beyond health-focused products, the company provides diverse service offerings. Under its Happy Buy platform, it delivers e-commerce agency and marketing services to small and medium-sized businesses, as well as offering e-commerce solutions, digital information, and advertising services to online retailers and manufacturers. Furthermore, through the Taochejun platform, the group facilitates secure vehicle transactions, automobile procurement, and financial support for car manufacturers. Happiness-branded goods are distributed via a broad network of channels, including independent distributors, major pharmacy chains, shopping centers, and supermarkets. Founded in 2004, the company is headquartered in Nanping, PRC.

Market snapshot

Symbol
HAPP
Price
$4.50
Day change
+1.12%
Market cap
$31.3M
P/E ratio
-0.17x
52-week range
2.08-7.4
Sector
Consumer Defensive
Industry
Packaged Foods

Peer companies

  • Meta Data Limited (AIU)
  • Big Lots, Inc. (BIGGQ)
  • Heritage Distilling Holding Company, Inc. (CASK)
  • Calyxt, Inc. (CLXT)
  • Gravitas Education Holdings, Inc. (GEHI)
  • CIMG Inc. (IMG)
  • Pingtan Marine Enterprise Ltd. (PME)
  • The Real Good Food Company, Inc. (RGF)

Open Happiness Development Group Limited (HAPP) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.